Skip to main content
PolicySpeak
← All files
ZH

ZENDAL HEALTH

Company · Spain · EU Transparency Register 2267186101667-23

1
position filed
in the 687 files tracked
1
legislative file
of 687 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 687 consultation files tracked so far (60,344 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1244 companies & groups on this site, they rank #1242 by legislative files engaged, a count of participation, not a measure of influence.

0.4
declared lobbying FTE
self-declared
€50K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2025
in the register since

Declares membership of

  • FARMAINDUSTRIA (www.farmaindustria.es): Farmaindustria is the National Trade Association of the Spanish based pharmac…
  • VETERINDUSTRIA (www.veterindustria.com): the National Trade Association of the Spanish Animal Health based pharmaceut…
  • BIOGA (www.bioga.org): Non-profit business association that supports the value chain of the biotechnology sector with…
  • ASEBIO (www.asebio.com): Spanish Bioindustry Association. AseBio has been uniting and representing the interests of c…
  • Chamber of Commerce of Tuy (www.camaratui.es)

Self-declared to the EU Transparency Register (snapshot 27 Oct 2026).

Register category
Companies & groups
Registered as
Zendal Health (n/a)
Head office
O Porriño, Spain

Self-declared to the EU Transparency Register (snapshot 27 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track ZENDAL in PolicySpeak: request access →

Follow ZENDAL HEALTH

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at ZENDAL HEALTH? so we know who speaks for it.

Their record over time

ZENDAL HEALTH filed 1 position on 22 Oct 2026, across 1 of the 687 legislative files tracked here.

What they argued

"Diversify EU" instrumentfiled 22 Oct 2026source

El riesgo en la cadenas de suministro de materiales críticos es especialmente elevado y difícil de mitigar dentro de las cadenas de suministro de la Industria Farmacéutica, especialmente en lo relativo a la fabricación de productos biológicos y biofármacos mediante el uso de procesos biotecnológicos.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put ZENDAL HEALTH next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from ZENDAL HEALTH’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.